Thrombopoietin and Mean Platelet Volume in Coronary Artery Disease

Overview

Journal Clin Cardiol

Specialty Cardiology & Vascular Diseases

Date 2001 May 11

PMID 11346249

Citations 41

Authors

H Senaran

M Ileri

A Altinbas

A Kosar

E Yetkin

M Ozturk

Y Karaaslan

S Kirazli

Affiliations

Soon will be listed here.

Abstract

Background: Large platelets are shown to be hemostatically more active. It has been suggested that mean platelet volume (MPV) is increased during acute myocardial infarction (AMI) and unstable angina pectoris (USAP). However, the underlying mechanism of the phenomenon remains unclear.

Hypothesis: In this study, platelets, MPV, and thrombopoietin (TP) levels were investigated in patients with coronary artery disease (CAD) and healthy controls.

Methods: Twenty patients with AMI and 20 patients with USAP were included in this study. Seventeen healthy adult subjects served as controls. Venous blood samples of the subjects were drawn within 12 h after admission. Thrombopoietin levels were measured by ELISA and platelet counts and MPV were assayed by autoanalyzer.

Results: Patients with AMI and USAP had higher platelet counts than those in the control group. Although the platelet counts were slightly higher in AMI than in USAP, this did not reach statistical significance. Mean platelet volume and levels of TP were found to be elevated in patients with AMI and USAP compared with control subjects (p < 0.001). Thrombopoietin levels were higher in AMI than USAP, but this was not statistically significant. There was a positive correlation between TP levels and MPV values (p < 0.05).

Conclusion: Increased TP levels may increase both platelet counts and platelet size, resulting in hemostatically more active platelets, which may contribute to the development and progression of CAD.

Citing Articles

Platelet Function, Platelet Size and Content of Reticulated Platelets: Interactions in Patients Receiving Dual Antiplatelet Therapy.

Bodrova V, Shustova O, Golubeva N, Alieva A, Vlodzyanovsky V, Pevzner D Cells. 2024; 13(20.

PMID: 39451230 PMC: 11506637. DOI: 10.3390/cells13201712.

Genomic Variation Affecting MPV and PLT Count in Association with Development of Ischemic Stroke and Its Subtypes.

Ludhiadch A, Sulena , Singh S, Chakraborty S, Sharma D, Kulharia M Mol Neurobiol. 2023; 60(11):6424-6440.

PMID: 37453995 DOI: 10.1007/s12035-023-03460-2.

The Relationship of Plasma Aterogenity Index and Mean Platelet Volume with the Risk of Development of 1-Year Total Major Adverse Cardiac Event in Patients with Non-ST Elevation Myocardial Infarction.

Allahverdiyev A, Koyuncu I, Kuru B, Allahverdiyeva A, Ertas F Int J Angiol. 2023; 32(2):81-87.

PMID: 37207006 PMC: 10191686. DOI: 10.1055/s-0043-1764223.

Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia.

Dlouha D, Blaha M, Rohlova E, Hubacek J, Lanska V, Visek J Genes (Basel). 2021; 12(10).

PMID: 34680994 PMC: 8535274. DOI: 10.3390/genes12101599.

Immunoprofiling of Nonarteritic Anterior Ischemic Optic Neuropathy.

Mesentier-Louro L, Stell L, Yan Y, Montague A, De Jesus Perez V, Liao Y Transl Vis Sci Technol. 2021; 10(8):17.

PMID: 34264294 PMC: 8288058. DOI: 10.1167/tvst.10.8.17.

References

Eaton D, de Sauvage F . Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol. 1997; 25(1):1-7. View

BRUCE R . Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res. 1971; 3(6):323-32. View

de Sauvage F, Luoh S, Ryan A, Dowd M, Eaton D, Moore M . Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996; 183(2):651-6. PMC: 2192470. DOI: 10.1084/jem.183.2.651. View

Threatte G, Adrados C, EBBE S, BRECHER G . Mean platelet volume: the need for a reference method. Am J Clin Pathol. 1984; 81(6):769-72. DOI: 10.1093/ajcp/81.6.769. View

Kaushansky K . Thrombopoietin: the primary regulator of platelet production. Blood. 1995; 86(2):419-31. View

Emmons R, Reid D, Cohen R, Meng G, Young N, Dunbar C . Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood. 1996; 87(10):4068-71. View

Trowbridge E, Martin J . The platelet volume distribution: a signature of the prethrombotic state in coronary heart disease?. Thromb Haemost. 1987; 58(2):714-7. View

Wendling F, Han Z . Positive and negative regulation of megakaryocytopoiesis. Baillieres Clin Haematol. 1997; 10(1):29-45. DOI: 10.1016/s0950-3536(97)80049-2. View

Giles H, Smith R, Martin J . Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994; 24(1):69-72. DOI: 10.1111/j.1365-2362.1994.tb02062.x. View

10.

Pizzulli L, Yang A, Martin J, Luderitz B . Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J. 1998; 19(1):80-4. DOI: 10.1053/euhj.1997.0747. View

11.

Villeval J, Titeux M, Lok S, Vainchenker W, Wendling F . Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood. 1996; 88(7):2578-84. View

12.

Smyth D, Martin J, Michalis L, Bucknall C, Jewitt D . Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest. 1993; 23(6):361-7. DOI: 10.1111/j.1365-2362.1993.tb02037.x. View

13.

Martin J, Bath P, Burr M . Influence of platelet size on outcome after myocardial infarction. Lancet. 1991; 338(8780):1409-11. DOI: 10.1016/0140-6736(91)92719-i. View

14.

McCarty J, Sprugel K, Fox N, Sabath D, Kaushansky K . Murine thrombopoietin mRNA levels are modulated by platelet count. Blood. 1995; 86(10):3668-75. View

15.

von dem Borne A, Folman C, Linthorst G, Porcelijn L, van den Oudenrijn S, van der Schoot E . Thrombopoietin and its receptor: structure, function and role in the regulation of platelet production. Baillieres Clin Haematol. 1999; 11(2):409-26. DOI: 10.1016/s0950-3536(98)80058-9. View

16.

Fielder P, Hass P, Nagel M, Stefanich E, Widmer R, Bennett G . Human platelets as a model for the binding and degradation of thrombopoietin. Blood. 1997; 89(8):2782-8. View

17.

Halbmayer W, Haushofer A, Radek J, Schon R, Deutsch M, Fischer M . Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease. Coron Artery Dis. 1995; 6(5):397-402. DOI: 10.1097/00019501-199505000-00007. View

18.

Stahl C, Zucker-Franklin D, Evatt B, Winton E . Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates. Blood. 1991; 78(6):1467-75. View

19.

Martin J, Plumb J, Kilbey R, Kishk Y . Changes in volume and density of platelets in myocardial infarction. Br Med J (Clin Res Ed). 1983; 287(6390):456-9. PMC: 1548755. DOI: 10.1136/bmj.287.6390.456. View

20.

Fielder P, Gurney A, Stefanich E, Marian M, Moore M, de Sauvage F . Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 1996; 87(6):2154-61. View